Apollo Hospitals and Ion Beam Applications (IBA) have announced a partnership to introduce the Proteus One system in India, which includes the DynamicARC beam delivery technology. This system is subject to statutory approvals and is expected to revolutionize cancer treatment in the country.
Proton therapy, an effective treatment for tumours of the Central Nervous System, head and neck, pediatric, and urological cancers, is expected to become a game-changer in the fight against cancer. The global burden of cancer is projected to increase to 21.4 million incident cases by 2030, with India ranking third in terms of absolute incidence number, contributing 7.5%. The Proteus One system will enable Apollo Hospitals to offer personalized, precise, and highly effective treatment for cancer patients.
According to Dr. Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals, “Cancer care is evolving rapidly, and at Apollo, we remain steadfast in our mission to stay ahead of this evolution. The introduction of the Proteus One system is a significant leap towards personalized, precise, and highly effective treatment for cancer patients.”
Apollo Hospitals, which has already introduced Proton Therapy in India in 2019, has seen over 2,000 patients from 147 countries benefit from this cutting-edge technology. The introduction of the Proteus One system is expected to further accelerate the fight against cancer in India and provide new hope to patients and their families.
The partnership between Apollo Hospitals and IBA demonstrates the commitment of both organizations to stay at the forefront of medical technology and provide the best possible care to patients. With the Proteus One system, Apollo Hospitals is poised to take cancer treatment to new heights, offering more effective and personalized care to patients across India and beyond.